Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 137.85 EUR -0.25% Market Closed
Market Cap: 59.9B EUR
Have any thoughts about
Merck KGaA?
Write Note

Merck KGaA
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Merck KGaA
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Merck KGaA
XETRA:MRK
Current Portion of Long-Term Debt
€3.5B
CAGR 3-Years
8%
CAGR 5-Years
-2%
CAGR 10-Years
6%
ATAI Life Sciences NV
NASDAQ:ATAI
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Current Portion of Long-Term Debt
€4.5B
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
4%
MPH Health Care AG
XETRA:93M1
Current Portion of Long-Term Debt
€7.4k
CAGR 3-Years
23%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Current Portion of Long-Term Debt
€120.9m
CAGR 3-Years
67%
CAGR 5-Years
10%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Current Portion of Long-Term Debt
€8.2m
CAGR 3-Years
224%
CAGR 5-Years
100%
CAGR 10-Years
N/A
No Stocks Found

Merck KGaA
Glance View

Market Cap
59.9B EUR
Industry
Pharmaceuticals

In the heart of Darmstadt, Germany, Merck KGaA stands as a testament to innovation and resilience, tracing its roots back to 1668. A bastion of scientific advancement and a pioneer in the world of chemistry and pharmaceuticals, Merck has evolved through centuries of discovery and transformation. Originally a humble pharmacy, Merck has grown into a global powerhouse with a unique structure, being one of the oldest pharmaceutical and chemical companies in the world still owned by the founding family. Though its path has been influenced by numerous historical events, Merck has adeptly navigated the shifting sands of time, transforming itself into a multifaceted conglomerate that thrives on its dual strategy—life sciences and performance materials. In the modern age, Merck KGaA operates through three well-defined sectors: Healthcare, Life Science, and Electronics. Its Healthcare division plays a formidable role, developing innovative drugs, with a focus on oncology, neurology, and immunology, providing cutting-edge treatments that improve patient lives globally. Meanwhile, the Life Science arm caters to researchers and scientists, offering an extensive portfolio of lab materials, high-tech tools, and equipment essential for groundbreaking research across various industries. The Electronics division, dedicated to performance materials, supplies high-quality substances crucial for the electronics and automotive industries, including liquid crystals and highly sophisticated semiconductor solutions. Through these divisions, Merck KGaA not only generates substantial revenue but also drives progress by supplying critical products that are indispensable to the modern technological landscape.

MRK Intrinsic Value
147.31 EUR
Undervaluation 6%
Intrinsic Value
Price

See Also

What is Merck KGaA's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
3.5B EUR

Based on the financial report for Sep 30, 2024, Merck KGaA's Current Portion of Long-Term Debt amounts to 3.5B EUR.

What is Merck KGaA's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
6%

Over the last year, the Current Portion of Long-Term Debt growth was 149%. The average annual Current Portion of Long-Term Debt growth rates for Merck KGaA have been 8% over the past three years , -2% over the past five years , and 6% over the past ten years .

Back to Top